You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

AVINZA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Avinza, and what generic alternatives are available?

Avinza is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Avinza

A generic version of AVINZA was approved as morphine sulfate by HOSPIRA on May 11th, 1988.

  Try a Trial

Drug patent expirations by year for AVINZA
Drug Sales Revenue Trends for AVINZA

See drug sales revenues for AVINZA

Recent Clinical Trials for AVINZA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Early Phase 1
M.D. Anderson Cancer CenterEarly Phase 1
Isfahan University of Medical SciencesPhase 2/Phase 3

See all AVINZA clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for AVINZA
Paragraph IV (Patent) Challenges for AVINZA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AVINZA Extended-release Capsules morphine sulfate 45 mg and 75 mg 021260 1 2009-08-11
AVINZA Extended-release Capsules morphine sulfate 30 mg, 60 mg, 90 mg and 120 mg 021260 1 2007-06-04

US Patents and Regulatory Information for AVINZA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-001 Mar 20, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-006 Dec 18, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-005 Dec 18, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-002 Mar 20, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AVINZA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-001 Mar 20, 2002 ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-004 Mar 20, 2002 ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-005 Dec 18, 2008 ⤷  Try a Trial ⤷  Try a Trial
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-003 Mar 20, 2002 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AVINZA

See the table below for patents covering AVINZA around the world.

Country Patent Number Title Estimated Expiration
Canada 2306333 FORMULATION MULTIPARTICULAIRE DE MORPHINE ORALE (ORAL MORPHINE MULTIPARTICULATE FORMULATION) ⤷  Try a Trial
Australia 5408098 ⤷  Try a Trial
Canada 2558783 FORMULATION ORALE MULTIPARTICULAIRE DE MORPHINE (ORAL MORPHINE MULTIPARTICULATE FORMULATION) ⤷  Try a Trial
South Africa 9809463 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.